Expression of osteoprotegerin (OPG), TNF related apoptosis inducing ligand (TRAIL), and receptor activator of nuclear factor κB ligand (RANKL) in human breast tumours

BACKGROUND: Osteoprotegerin (OPG) is involved in the regulation of bone turnover through binding to the receptor activator of nuclear factor κB ligand (RANKL), and has also been reported to be a potential survival factor for several different cell types. The survival effects are mediated through inh...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Van Poznak, C, Cross, S S, Saggese, M, Hudis, C, Panageas, K S, Norton, L, Coleman, R E, Holen, I
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Group 2006
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC1860269/
https://ncbi.nlm.nih.gov/pubmed/16394281
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jcp.2005.026534
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak